These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1200 related articles for article (PubMed ID: 9270876)

  • 21. Analysis of proteoglycan expression in developing chicken brain: characterization of a heparan sulfate proteoglycan that interacts with the neural cell adhesion molecule.
    Burg MA; Halfter W; Cole GJ
    J Neurosci Res; 1995 May; 41(1):49-64. PubMed ID: 7674377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
    Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
    Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opticin binds to heparan and chondroitin sulfate proteoglycans.
    Hindson VJ; Gallagher JT; Halfter W; Bishop PN
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4417-23. PubMed ID: 16303928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colocalization of a large heterodimeric proteoglycan with basement membrane proteins in cultured cells.
    Faber V; Quentin-Hoffmann E; Breuer B; Schittny J; Völker W; Kresse H
    Eur J Cell Biol; 1992 Oct; 59(1):37-46. PubMed ID: 1468446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor.
    Gordon PB; Choi HU; Conn G; Ahmed A; Ehrmann B; Rosenberg L; Hatcher VB
    J Cell Physiol; 1989 Sep; 140(3):584-92. PubMed ID: 2528552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth modulation and proteoglycan turnover in cultured mesangial cells.
    Wang A; Fan MY; Templeton DM
    J Cell Physiol; 1994 May; 159(2):295-310. PubMed ID: 8163569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
    Friedrich MV; Göhring W; Mörgelin M; Brancaccio A; David G; Timpl R
    J Mol Biol; 1999 Nov; 294(1):259-70. PubMed ID: 10556044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and partial characterization of a cell-surface heparan sulfate proteoglycan from embryonic rat spinal cord.
    Giuseppetti JM; McCarthy JB; Letourneau PC
    J Neurosci Res; 1994 Apr; 37(5):584-95. PubMed ID: 8028039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
    Graham LD; Whitelock JM; Underwood PA
    Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA; Quinn CC; Wang W; Tromp G
    J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial proteoglycans inhibit bFGF binding and mitogenesis.
    Forsten KE; Courant NA; Nugent MA
    J Cell Physiol; 1997 Aug; 172(2):209-20. PubMed ID: 9258342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparan sulfate and chondroitin sulfate proteoglycans inhibit E-selectin binding to endothelial cells.
    Luo J; Kato M; Wang H; Bernfield M; Bischoff J
    J Cell Biochem; 2001; 80(4):522-31. PubMed ID: 11169736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perlecan in the basement membrane of corneal epithelium serves as a site for P. aeruginosa binding.
    Chen LD; Hazlett LD
    Curr Eye Res; 2000 Apr; 20(4):260-7. PubMed ID: 10806439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteoglycan and glycosaminoglycan synthesis by cultured rat mesangial cells.
    Groggel GC; Hovingh P; Linker A
    J Cell Physiol; 1991 Jun; 147(3):455-9. PubMed ID: 1906068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of proteoglycans from human follicular fluid.
    Eriksen GV; Carlstedt I; Mörgelin M; Uldbjerg N; Malmström A
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):613-20. PubMed ID: 10359644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that cell surface heparan sulfate is involved in the high affinity thrombin binding to cultured porcine aortic endothelial cells.
    Shimada K; Ozawa T
    J Clin Invest; 1985 Apr; 75(4):1308-16. PubMed ID: 3157703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High glucose-induced alterations in subendothelial matrix perlecan leads to increased monocyte binding.
    Vogl-Willis CA; Edwards IJ
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):858-63. PubMed ID: 15031130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
    Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
    Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.